Platform
Modules
By sector
By sector
By standard
Blog
News
Events
STANAG 2939
Defence blood establishments, medical logistics units and equipment suppliers working to a contract that invokes STANAG 2939 or the AMedP-1.1 publication it covers
STANAG 2939 is NATO's ratification agreement covering AMedP-1.1 Edition B, which sets minimum requirements for blood, blood donors and associated equipment used in NATO transfusion support.
STANAG 2939 is the NATO Standardization Agreement covering minimum requirements for blood, blood donors and associated equipment, in the form of the Allied Medical Publication AMedP-1.1, Edition B. This is Edition 7, promulgated 13 July 2026, superseding Edition 6 of 3 September 2018; this edition's own stated addition is that "categories of blood and blood component sources are added".
A STANAG is the agreement by which NATO nations commit to implement a standard, not the technical specification itself. STANAG 2939's own text is short and administrative: an aim, two interoperability requirements, the commitment to implement AMedP-1.1, a list of other related documents, and the ratification, implementation and review machinery. Participating nations "agree to implement the following standard", and the standard named is AMedP-1.1, Edition B. Anyone working out donor eligibility, testing, processing, labelling, transport, storage or traceability requirements needs AMedP-1.1's own text, not this cover agreement, which does not itself set out any of that detail.
The stated aim is interoperability, "to respond to the following interoperability requirements": a Common Blood Concept that includes a regulatory framework enabling blood and blood components to reach "as near to the point of need as practicable", and the exchange of blood and blood components between NATO Forces by way of the minimum requirements AMedP-1.1 sets. Once a nation implements the agreement, it commits to adopting "standardised equipment, in form, fit and function, to facilitate collection and transfusion of blood and blood components" and to exchanging information on blood management processes and procedures with other nations. Cross-acceptance between nations is explicit: if blood and blood components are acceptable within the supplying nation's own regulatory framework and this agreement, they are acceptable for use by NATO.
STANAG 2939 binds nations, not blood establishments, equipment suppliers or donors. It is effective "upon receipt for use by the participating nations and NATO bodies", and a given nation becomes bound to it through ratification, which NATO records in the NATO Standardization Documents Database (NSDD). Reporting duties differ by status: Allies and NATO bodies "shall provide implementation details through the electronic reporting tool", while partner nations are only invited to do the same. The document names no NATO-wide effective date - its own "NATO Effective Date (NED)" field reads "Not applicable" - so a blood establishment or supplier meets AMedP-1.1's requirements only where a nation has implemented the STANAG and a contract or tender says so.
STANAG 2939 describes no certification scheme and no audit of a company, a blood establishment or a product; it never uses the word "certified" or "certification" anywhere in its text. What it describes is nations reporting their ratification and implementation status to NATO, recorded in the NSDD. Where a blood establishment's work against AMedP-1.1's requirements is actually checked, the assessor and the evidence required come from the supplying nation's own regulatory framework and from whatever contract or national process invokes AMedP-1.1, not from this STANAG. A blood establishment's own licence, where one is required, is held against that national regulation, not against this agreement.
STANAG 2939 covers AMedP-1.1, the Allied Medical Publication that carries the actual blood, blood donor and equipment requirements. Reviews of the STANAG itself run under AAP-03. Its "Other Related Documents" list a further set of civil and national material without describing how any of it interacts with AMedP-1.1's requirements: three blood-labelling systems (ISBT Code 128, the French Monarch Code, and Eurocode IBLS), United States blood regulation (CFR Title 21 and the AABB's standards for blood banks and transfusion services), the UK's Blood Standards and Quality Regulations, Canada's Health Canada blood guidance and regulations, an EU directive on quality and safety for human blood and blood components, a newer EU regulation on substances of human origin, and two Council of Europe references edited by EDQM covering blood supply contingency planning and the preparation, use and quality assurance of blood components. None of these sit in our catalogue, so they are named here rather than linked.
The work STANAG 2939 and AMedP-1.1 describe - collecting, testing, processing, labelling, transporting, storing and tracking blood, and standardising the equipment used to do it - is clinical and logistics work carried out by a national blood service or a defence medical unit, not something a compliance platform performs.
What ComplyTrain does for that kind of work in general is give an organisation working to a contract that invokes AMedP-1.1 a single, auditable place to hold its procedures, the training records for the people doing that work, and the evidence trail - non-conformances, corrective actions, document control - that a customer's quality representative or a government surveillance visit will ask to see.
ComplyTrain does not collect, test or store blood, and it does not determine whether a blood establishment's equipment or processes meet AMedP-1.1's requirements. That is clinical and engineering work, carried out against the publication itself, the supplying nation's own blood regulation, and the contract's own requirements.
Which STANAGs and Allied Publications actually apply to a given programme is set by the contract and the customer's quality clause, not by us. Browse the explorer to see what sits alongside STANAG 2939 and AMedP-1.1, and talk to us about the evidence trail once you know which ones are in your contract.
Tell us how you need to work with STANAG 2939 and what you need from it. We will come back to you about what ComplyTrain can do.
Thank you. Your list is on its way to your inbox, and we will come back to you on what working with these standards in ComplyTrain involves, usually within one business day.
Only where a nation has ratified and implemented it, and it reaches a blood establishment or supplier only where a contract or tender invokes AMedP-1.1. The STANAG's own "NATO Effective Date (NED)" field reads "Not applicable", so there is no blanket start date to point to.
STANAG 2939 is the NATO ratification agreement; AMedP-1.1, Edition B is the Allied Medical Publication that actually sets the minimum requirements for blood, blood donors and associated equipment. Ratifying STANAG 2939 is how a nation commits to implement AMedP-1.1.
No. STANAG 2939 describes nations ratifying and reporting implementation to NATO, recorded in the NATO Standardization Documents Database. It names no certification or audit scheme for a company, a blood establishment or a product. Where a blood establishment holds a licence, that licence is held against its national blood regulation, not against this agreement.
The document states that this edition supersedes "STANAG 2939, Edition 6 dated 3 September 2018", and that "categories of blood and blood component sources are added". It does not otherwise describe what changed between the two editions.
No. The STANAG names donation, testing, processing, labelling, transport, storage and traceability only as areas AMedP-1.1 covers; the requirements themselves are in AMedP-1.1's own text, not in this cover agreement.
One system for the whole compliance programme. Start with the module you need most.
Collect information the same way every time, and decide in advance what happens next.
Know whether your controls are operating, not just whether a policy says they exist.
Turn the compliance work you already know about into a plan with owners, dependencies and dates.
Know what you can offer, and hold the evidence behind every configuration you offer it in.
Eight built-in reports across every module, scheduled, delivered, and filed where the evidence lives.
The sector news that matters to your organisation - read and rated by AI, and delivered as a scheduled digest in your own language.
AI reads the tender pack and pulls out the requirements, deadlines and rules - then helps you draft the response from your own approved content, with you reviewing every step.
One current register of the suppliers and partners you depend on - each risk-assessed, re-assessing itself on schedule, and wired straight into your risk register.
See every requirement you face - across every standard, plus your own contracts and policies - traced to the documents, evidence and processes that satisfy it.
Identify, score, treat and review your risks in one place - with AI to help anyone run a proper assessment, and a defensible trail behind every decision.
Assign training, prove it was understood, and hold the competence records an auditor asks for.
Draft compliance documents with AI, keep every version under control, and export them beautifully branded - all in one place.
Audits, corrective actions, processes and approvals in one quality system, organised around ISO 9001.
Medical device manufacturers operate under more regulatory pressure than almost any other sector outside pharmaceuticals. The rules govern how you design a device, how you make it, how you track it after it ships, and how you respond when something goes wrong.
Learn how EU dual-use export controls apply to encryption, sensors, and software, how classification works under Annex I, and why sending source code by email can count as an export.
A practical way to turn in-your-head risk management into a register that survives staff turnover and answers the risk questions now showing up in tenders.